SOLICITATION NOTICE
B -- BERYLLIUM CONTRACT TRANSGENIC MOUSE MODEL
- Notice Date
- 6/12/2008
- Notice Type
- Presolicitation
- NAICS
- 541690
— Other Scientific and Technical Consulting Services
- Contracting Office
- Department of Health and Human Services, Centers for Disease Control and Prevention, Acquisition and Assistance Field Branch (Morgantown), 1095 Willowdale Road, Morgantown, West Virginia, 26505
- ZIP Code
- 26505
- Solicitation Number
- OOOHCCHB-2008-56240
- Archive Date
- 7/12/2008
- Point of Contact
- Kimberly P Groves, Phone: 304-285-5885
- E-Mail Address
-
kpg0@cdc.gov
- Small Business Set-Aside
- N/A
- Description
- NOTICE OF INTENT TO ISSUE A PURCHASE ORDER: The Centers for Disease Control and Prevention (CDC), the National Institute for Occupational Safety and Health, ALOSH, Morgantown, WV, intends to issue a purchase order on a sole source basis to The New York University School of Medicine, 57 Old Forge Road, Tuxedo, NY 10987. The purpose of this contract is to secure the services of an immunotoxicology expert to conduct exposure of the beryllium mouse model to different doses and different types of beryllium, and via different routes of administration (primarily skin versus lung). The outcome of the experiments will be measured by pathological quantification of lung granulomata and inflammation in animals sacrificed at 4 and 7 months. These outcomes will be determined by scientists in NIOSH. After validation of the animal model of CBD, dermal exposure will be evaluated as a possible route of sensitization. Based on an extensive literature search, we are confident that Terry Gordon, Ph.D. with the New York University School of Medicine is currently the only individual with a credible CBD mouse model, comprising three mouse strains with genetically engineered changes through "knock-in" of members of the HLA-DPBI gene family involved in CBD (one for each of the HLA-DPBI family members, designated: *0201, *0401 and *1701). Responsible sources that believe they possess the expertise and capabilities identified above are encouraged to submit to the Contracting Officer within 15 days from the posting date of this notice their capabilities statement and supporting information in the format they choose, not to exceed 10 pages. Please forward capabilities and supporting information to: Kimberly Groves, Reference: 000HCCHB-2008-56240, DHHS/PHS/CDC/NIOSH, 1095 Willowdale Road, Morgantown, WV 26505, or E-mail kpg0@cdc.gov or fax to 304-285-6083. The government will review any/all capabilities statements and and pricing information submitted and determine if other qualified sources do exist that could provide this requirement. Information received in response to this notice will be used solely for the purpose of determining whether to conduct a competitive procurement. All vendors must be registered in the Central Contractor Registry (CCR) prior to award of a federal contract. Vendors may register at www.ccr.gov. If no affirmative responses are received within 15 days, in accordance with FAR 13.106-1(b)(1), negotiations will be conducted with The New York University School of Medicine as the only source and a purchase order will be issued without any additional notices being posted. Original Point of Contact: Kimberly Groves, Purchasing Agent, Phone 304-285-5885, Fax 304-285-6083, Email kpg0@cdc.gov.
- Web Link
-
FedBizOpps Complete View
(https://www.fbo.gov/?s=opportunity&mode=form&id=5096fcffc5dd55c6150ee0c7db1a49c8&tab=core&_cview=1)
- Record
- SN01592608-W 20080614/080612220936-5096fcffc5dd55c6150ee0c7db1a49c8 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |